Fujian Aonong Biological Technology Group Incorporation Valuation
Is 603363 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 603363 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 603363 (CN¥4.09) is trading below our estimate of fair value (CN¥41.83)
Significantly Below Fair Value: 603363 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 603363?
Other financial metrics that can be useful for relative valuation.
What is 603363's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥3.56b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.7x |
Enterprise Value/EBITDA | -8.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 603363's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.6x | ||
002852 Daodaoquan Grain and OilLtd | 0.4x | n/a | CN¥3.0b |
600419 Xinjiang Tianrun Dairy | 1.1x | 11.2% | CN¥3.0b |
600354 Gansu Dunhuang Seed GroupLtd | 2.3x | n/a | CN¥2.9b |
300189 Hainan Shennong Technology | 14.4x | n/a | CN¥2.6b |
603363 Fujian Aonong Biological Technology Group Incorporation | 0.2x | 34.4% | CN¥3.6b |
Price-To-Sales vs Peers: 603363 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (4.6x).
Price to Earnings Ratio vs Industry
How does 603363's PE Ratio compare vs other companies in the CN Food Industry?
Price-To-Sales vs Industry: 603363 is good value based on its Price-To-Sales Ratio (0.2x) compared to the CN Food industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is 603363's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.2x |
Fair PS Ratio | 1x |
Price-To-Sales vs Fair Ratio: 603363 is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.